{"count": 4, "results": [{"_id": "31006191", "pmid": 31006191, "title": "[Effects of metformin on the expression of estrogen synthetase and ER mRNA in uterine leiomyoma tissues].", "journal": "Zhonghua Fu Chan Ke Za Zhi", "authors": ["Wang SY", "Xue Q", "Zhou YF", "Yin L"], "date": "2019-04-25T00:00:00Z", "doi": "10.3760/cma.j.issn.0529-567x.2019.04.007", "meta_date_publication": "2019 Apr 25", "meta_volume": "54", "meta_issue": "4", "meta_pages": "249-254", "score": 50066.12, "text_hl": "[Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on the expression of @GENE_CYP19A1 @GENE_1588 @@@estrogen synthetase@@@ and @GENE_EREG @GENE_2069 @@@ER@@@ mRNA in @<m>DISEASE_150699</m> @DISEASE_OMIM:150699 @@@uterine leiomyoma@@@ tissues].", "citations": {"NLM": "Wang SY, Xue Q, Zhou YF, Yin L. [Effects of metformin on the expression of estrogen synthetase and ER mRNA in uterine leiomyoma tissues]. Zhonghua Fu Chan Ke Za Zhi. 2019 Apr 25;54(4):249-254. PMID: 31006191", "BibTeX": "@article{31006191, title={[Effects of metformin on the expression of estrogen synthetase and ER mRNA in uterine leiomyoma tissues].}, author={Wang SY and Xue Q and Zhou YF and Yin L}, journal={Zhonghua Fu Chan Ke Za Zhi}, volume={54}, number={4}, pages={249-254}}"}}, {"_id": "31897287", "pmid": 31897287, "pmcid": "PMC6920594", "title": "Metformin use is associated with a lower risk of uterine leiomyoma in female type 2 diabetes patients", "journal": "Ther Adv Endocrinol Metab", "authors": ["Tseng CH"], "date": "2019-12-18T00:00:00Z", "doi": "10.1177/2042018819895159", "meta_date_publication": "2019", "meta_volume": "10", "meta_issue": "", "meta_pages": "2042018819895159", "score": 50066.055, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use is associated with a lower risk of @<m>DISEASE_150699</m> @DISEASE_OMIM:150699 @@@uterine leiomyoma@@@.", "citations": {"NLM": "Tseng CH. Metformin use is associated with a lower risk of uterine leiomyoma in female type 2 diabetes patients Ther Adv Endocrinol Metab. 2019;10():2042018819895159. PMID: 31897287", "BibTeX": "@article{31897287, title={Metformin use is associated with a lower risk of uterine leiomyoma in female type 2 diabetes patients}, author={Tseng CH}, journal={Ther Adv Endocrinol Metab}, volume={10}, pages={2042018819895159}}"}}, {"_id": "22835064", "pmid": 22835064, "title": "The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway.", "journal": "Gynecol Endocrinol", "authors": ["Li B", "Takeda T", "Tsuiji K", "Kondo A", "Kitamura M", "Wong TF", "Yaegashi N"], "date": "2013-01-01T00:00:00Z", "doi": "10.3109/09513590.2012.706668", "meta_date_publication": "2013 Jan", "meta_volume": "29", "meta_issue": "1", "meta_pages": "87-90", "score": 50065.312, "text_hl": "The antidiabetic drug @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ inhibits @<m>DISEASE_150699</m> @DISEASE_OMIM:150699 @@@uterine leiomyoma@@@ cell proliferation via an @GENE_PRKAA2 @GENE_78975 @@@AMP-activated protein kinase@@@ signaling pathway.", "citations": {"NLM": "Li B, Takeda T, Tsuiji K, Kondo A, Kitamura M, Wong TF, Yaegashi N. The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway. Gynecol Endocrinol. 2013 Jan;29(1):87-90. PMID: 22835064", "BibTeX": "@article{22835064, title={The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway.}, author={Li B and Takeda T and Tsuiji K and Kondo A and Kitamura M and Wong TF and Yaegashi N}, journal={Gynecol Endocrinol}, volume={29}, number={1}, pages={87-90}}"}}, {"_id": "25179820", "pmid": 25179820, "title": "The anti-diabetic drug metformin inhibits vascular endothelial growth factor expression via the mammalian target of rapamycin complex 1/hypoxia-inducible factor-1alpha signaling pathway in ELT-3 cells.", "journal": "Mol Cell Endocrinol", "authors": ["Tadakawa M", "Takeda T", "Li B", "Tsuiji K", "Yaegashi N"], "date": "2015-01-05T00:00:00Z", "doi": "10.1016/j.mce.2014.08.012", "meta_date_publication": "2015 Jan 5", "meta_volume": "399", "meta_issue": "", "meta_pages": "1-8", "score": 50058.594, "text_hl": "These results indicate that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may represent an effective alternative in the future treatment of @<m>DISEASE_150699</m> @DISEASE_OMIM:150699 @@@uterine leiomyomas@@@. ", "citations": {"NLM": "Tadakawa M, Takeda T, Li B, Tsuiji K, Yaegashi N. The anti-diabetic drug metformin inhibits vascular endothelial growth factor expression via the mammalian target of rapamycin complex 1/hypoxia-inducible factor-1alpha signaling pathway in ELT-3 cells. Mol Cell Endocrinol. 2015 Jan 5;399():1-8. PMID: 25179820", "BibTeX": "@article{25179820, title={The anti-diabetic drug metformin inhibits vascular endothelial growth factor expression via the mammalian target of rapamycin complex 1/hypoxia-inducible factor-1alpha signaling pathway in ELT-3 cells.}, author={Tadakawa M and Takeda T and Li B and Tsuiji K and Yaegashi N}, journal={Mol Cell Endocrinol}, volume={399}, pages={1-8}}"}}]}